Amy Haseley

619 total citations
8 papers, 359 citations indexed

About

Amy Haseley is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Amy Haseley has authored 8 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Amy Haseley's work include Virus-based gene therapy research (7 papers), Herpesvirus Infections and Treatments (5 papers) and CAR-T cell therapy research (3 papers). Amy Haseley is often cited by papers focused on Virus-based gene therapy research (7 papers), Herpesvirus Infections and Treatments (5 papers) and CAR-T cell therapy research (3 papers). Amy Haseley collaborates with scholars based in United States, Japan and Netherlands. Amy Haseley's co-authors include Balveen Kaur, Ji Young Yoo, E. Antonio Chiocca, Christopher Alvarez‐Breckenridge, Abhik Ray Chaudhury, Kimerly Powell, Anna Bratasz, Kazuo Okemoto, Jeffrey Wojton and William F. Goins and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Amy Haseley

8 papers receiving 353 citations

Peers

Amy Haseley
Richard J. Aguilar United States
Toru Ichinose Japan
Ibrahim Ragab Eissa Japan
Yves Poitevin Switzerland
Shohei Miyamoto Japan
Min Liang China
Hong-My Nguyen United States
Petri Nokisalmi Finland
Jiankai Liang China
CM Kramm United States
Richard J. Aguilar United States
Amy Haseley
Citations per year, relative to Amy Haseley Amy Haseley (= 1×) peers Richard J. Aguilar

Countries citing papers authored by Amy Haseley

Since Specialization
Citations

This map shows the geographic impact of Amy Haseley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Haseley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Haseley more than expected).

Fields of papers citing papers by Amy Haseley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Haseley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Haseley. The network helps show where Amy Haseley may publish in the future.

Co-authorship network of co-authors of Amy Haseley

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Haseley. A scholar is included among the top collaborators of Amy Haseley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Haseley. Amy Haseley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Okemoto, Kazuo, Kazue Kasai, Amy Haseley, et al.. (2013). DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas. Clinical Cancer Research. 19(21). 5952–5959. 23 indexed citations
2.
Currier, Mark A., Allyson Sholl, Kelly Crawford, et al.. (2013). VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells. Molecular Therapy. 21(5). 1014–1023. 34 indexed citations
3.
Okemoto, Kazuo, et al.. (2013). STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells. PLoS ONE. 8(8). e71932–e71932. 30 indexed citations
4.
Haseley, Amy, Jeffrey Wojton, Lianbo Yu, et al.. (2012). Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in Glioma. Cancer Research. 72(6). 1353–1362. 51 indexed citations
5.
Yoo, Ji Young, Jason Pradarelli, Amy Haseley, et al.. (2012). Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV. Clinical Cancer Research. 18(18). 4931–4941. 34 indexed citations
6.
Uchida, Hiroaki, Kenji Nakano, William F. Goins, et al.. (2012). Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus. Molecular Therapy. 21(3). 561–569. 96 indexed citations
7.
Yoo, Ji Young, Amy Haseley, Anna Bratasz, et al.. (2011). Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-expressing Oncolytic Virus. Molecular Therapy. 20(2). 287–297. 44 indexed citations
8.
Haseley, Amy, Christopher Alvarez‐Breckenridge, Abhik Ray Chaudhury, & Balveen Kaur. (2008). Advances in Oncolytic Virus Therapy for Glioma. PubMed. 4(1). 1–13. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard J. Aguilar Breakdown of academic impact, for papers by Toru Ichinose Breakdown of academic impact, for papers by Ibrahim Ragab Eissa Breakdown of academic impact, for papers by Yves Poitevin Breakdown of academic impact, for papers by Shohei Miyamoto Breakdown of academic impact, for papers by Min Liang Breakdown of academic impact, for papers by Hong-My Nguyen Breakdown of academic impact, for papers by Petri Nokisalmi Breakdown of academic impact, for papers by Jiankai Liang Breakdown of academic impact, for papers by CM Kramm
Rankless by CCL
2026